<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="54307">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02399150</url>
  </required_header>
  <id_info>
    <org_study_id>BIOMAB</org_study_id>
    <nct_id>NCT02399150</nct_id>
  </id_info>
  <brief_title>Biomarkers in Acute Abdomen</brief_title>
  <acronym>BIOMAB</acronym>
  <official_title>Biomarkers in Acute Abdomen (BIOMAB)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pitié-Salpêtrière Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association pour la Recherche et la Formation en Anesthésie Analgésie Réanimation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pitié-Salpêtrière Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: In the emergency setting, acute abdominal pain is a diagnostic challenge, as
      pain is a subjective measure, and serious causes needing surgical intervention do not always
      meet the clinical picture. Biomarkers measuring the individual stress or pain level may aid
      in identifying surgical emergencies, but there are many influencing factors that have to be
      taken into account.

      Objective: To evaluate defined stress biomarkers for their diagnostic and prognostic utility
      in measuring pain, and to evaluate potential influencing or confounding factors.

      Design: Prospective observational study in 200 patients presenting to the emergency
      department with acute abdominal pain.

      Estimated duration: May 2015 - May 2016 Location Setting: Emergency Department (ED) of the
      Hôpital Universitaire Pitié-Salpétrière, Paris, France.

      Study population: 200 patients presenting to the ED with acute abdomen

      Eligibility criteria:

        -  Inclusion criteria: Presentation at ED with acute abdominal pain, aged at least 18
           years

        -  Exclusion criteria: no informed consent, pregnancy, homeless, no social assurance

      Procedure:

      Patients presenting to the ED with acute abdominal pain will be included after informed
      consent is given. Blood and saliva samples will be drawn initially and after 4 hours, and
      baseline data assessed. All diagnostic procedures results and diagnosis made by the treating
      physicians as well as initiated treatment will be recorded Final diagnosis and outcome will
      be assessed by 2-week-telephone interview.

      Measurement of candidate biomarkers will be performed in collected material. Copeptin and
      SAA will be measured as potential biomarkers, as a control value, cortisol will be obtained.
      Other biomarkers will be in consideration, depending upon availability and financial
      aspects.

      Safety evaluations: All recommendations outlined in the ICH Guidelines for Good Clinical
      Practice will be adhered to throughout this trial.

      Sample size considerations: The number of patients of this pilote study is based on the
      estimate of 25 % or 50 of acute abdomen patients to have a surgical emergency.

      Significance of the study: If a biomarker is found that safely discriminates between
      surgical urgency and harmless abdominal pain, this will spare radiologic exposure in often
      young patients and will aid in optimized allocation of health care resources.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic value of biomarkers for discriminating between self-limiting abdominal pain and acute surgical emergency</measure>
    <time_frame>15 days</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Acute Abdominal Pain</condition>
  <arm_group>
    <arm_group_label>Acute Abdominal Pain</arm_group_label>
    <description>patients presenting to the ED with acute abdomen</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention as observational study</intervention_name>
    <arm_group_label>Acute Abdominal Pain</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EDTA and serum blood, saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients presenting to the ED with acute abdomen
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presentation at ED with acute abdominal pain, aged at least 18 years

        Exclusion Criteria:

          -  No informed consent, pregnancy, homeless, no social assurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Hausfater, MD, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service d'Accueil des Urgences, CHU Pitié-Salpêtrière, AP-HP et Université Pierre et Marie Curie Paris 06, Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Hausfater, MD, Pr</last_name>
    <phone>0033 1 42 17 72 40</phone>
    <email>pierre.hausfater@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claudine A Blum, MD</last_name>
    <phone>0041 76 303 07 57</phone>
    <email>claudineblum@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'Accueil des Urgences, CHU Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Hausfater, MD, Pr</last_name>
      <phone>00331 42 17 72 40</phone>
      <email>pierre.hausfater@psl.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Claudine A Blum, MD</last_name>
      <phone>0041 76 303 07 57</phone>
      <email>claudineblum@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 22, 2016</lastchanged_date>
  <firstreceived_date>March 23, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Groupe Hospitalier Pitie-Salpetriere</investigator_affiliation>
    <investigator_full_name>Hausfater Pierre</investigator_full_name>
    <investigator_title>Emergency Department</investigator_title>
  </responsible_party>
  <keyword>acute abdomen</keyword>
  <keyword>Pain</keyword>
  <keyword>stress biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Abdominal Pain</mesh_term>
    <mesh_term>Abdomen, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
